Sentinel Biomedical provides canine genetic cancer testing, Genomics, genome mapping and the comparative aspects of canine cancer.

Benanova Inc. has developed a cost-efficient, environmentally benign particle system (EbNPs) made of natural materials, which can leverage the functional properties of bioactive agents. This innovative, patent-pending technology can facilitate the development of highly efficient, application-customized and environmentally benign replacements for silver nanoparticle antimicrobials.